MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Post stroke Restless Limb Syndrome and its impact on sleep and life quality in patients in Rural Gujarat, India

    S. Desai, J. Darji, D. Desai (Anand, India)

    Objective: We aimed to assess the prevalence of RLS in patients with brain stroke and assess its impact on sleep and quality of life. We…
  • 2023 International Congress

    Subjective cognitive complaints in patients with progressive supranuclear palsy and corticobasal syndrome

    JS. Lee, JH. Ahn, J. Youn, JW. Cho (Seoul, Republic of Korea)

    Objective: In the present study, we evaluate a prevalence of subjective cognitive complaints (SCC)in patients with progressive supranuclear palsy (PSP) as well as clinical features…
  • 2023 International Congress

    Building a consensus conceptual model of meaningful symptoms and impacts in early Parkinson’s disease

    J. Adams, J. Mammen, C. Kopil, Y. Xiao, D. Stephenson, T. Simuni (Rochester, USA)

    Objective: To develop a consensus based conceptual model of meaningful symptoms and impacts in early Parkinson’s disease (PD) through aligning of PD qualitative research carried…
  • 2023 International Congress

    Alzheimer’s Disease Co-pathology and its Influence on Biofluid Biomarkers in Autopsied Subjects from the PPMI Study

    D. Coughlin, K. Hwang, E. Bayram, D. Galasko (San Diego, USA)

    Objective: To examine the relationship between biofluid biomarkers and post-mortem pathological findings in autopsied subjects from the Parkinson’s Progression Marker Initiative (PPMI). Background: The PPMI…
  • 2023 International Congress

    Operationalising goal setting as an outcome measure: Experience from the PRIME-UK randomised controlled trial

    E. Tenison, K. Lloyd, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: To select a suitable primary outcome for the evaluation of a multicomponent intervention for people with parkinsonism. Background: The multicomponent PRIME model of care,…
  • 2023 International Congress

    Glial neurotrophiz factor as a differential marker of Parkinson`s disease and vascular parkinsonism

    R. Matmurodov, E. Abduqodirov, R. Juraev, O. Naimov, B. Muminov, K. Khalimova, H. Daminova (Tashkent, Uzbekistan)

    Objective: To analysis of glial neurotrophic factor content in blood serum of patients with PD and VP. Background: Parkinson's disease (PD)  and vascular parkinsonism (VP)…
  • 2023 International Congress

    Analysis of the therapeutic potential of c-Abl inhibition in Multiple System Atrophy

    M. Werner, E. Bertin, A. Simmonet, E. Noé, P. Fernagut, J. Molina, K. Lowe, E. Bezard, J. Kordower (Atlanta, USA)

    Objective: IkT-148009 is a potent selective inhibitor of non-receptor Abelson Tyrosine Kinases (c-Abl kinases).  Our recent analysis of post-mortem brain tissue from patients with Multiple…
  • 2023 International Congress

    Contribution of MRI and machine learning approaches to the diagnosis of patients with early-stage parkinsonism in a situation of clinical uncertainty

    L. Chougar, A. Faucher, J. Faouzi, FX. Lejeune, F. Cormier, M. Vidailhet, O. Colliot, S. Lehericy, D. Grabli, B. Degos (PARIS, France)

    Objective: To determine whether MRI and machine learning approaches improve diagnostic accuracy in patients with early-stage parkinsonism compared to clinical criteria Background: Parkinson’s disease (PD)…
  • 2023 International Congress

    Digital mobility sub-study in the Parkinson’s Progressive Marker Initiative (PPMI) study.

    A. Mirelman, T. Simuni, C. Tanner, E. Flagg, A. Lorenzo, J. Dimos, C. Coffey, A. Siderowf, K. Marek (Tel Aviv, Israel)

    Objective: To test the feasibility and validity of digital mobility data for enrichment of the prodromal screening and to assess the sensitivity of these measures…
  • 2023 International Congress

    A systematic review of Action Observation Therapy for Parkinson’s disease rehabilitation.

    A. Ibrahim Abdelhamed, H. Samy, M. Elafifi, R. Hesham, M. Walid, M. Salah, M. Mohamed, R. Fekry, S. Elwaly, M. Zakzok, M. Fahmy Mohamed, M. Agaiby Amin, A. Melad Sedarous, M. Shafiek Saleh (Elfashn, Egypt)

    Objective: This systematic review summarizes all published outcomes of Parkinson’s patients treated with AOT. Background: Gait disorders in patients with Parkinson’s disease (PD) are caused…
  • « Previous Page
  • 1
  • …
  • 105
  • 106
  • 107
  • 108
  • 109
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley